Peer-reviewed veterinary case report
Sorafenib with or without co-interventions for hepatocellular carcinoma.
- Year:
- 2025
- Authors:
- Chen S et al.
- Affiliation:
- Beijing Tongren Hospital · China
Abstract
<h4>Objectives</h4>This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the beneficial and harmful effects of sorafenib, with or without co-interventions, versus placebo, no intervention, or the same co-interventions for adults, aged 18 and over, with hepatocellular carcinoma.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://europepmc.org/article/MED/40568833